| Utestående aktier | 113,314,529 shares |
| Insideraktier | 16 030 750 shares |
| Insynsägande | 14,15 % |
| Totalt antal insynspersoner | 25 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
1619 out of 10786
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Globus Medical, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Richard A Baron Senior VP and CFO - [O] | 0 | 0 | |
|
Clarus Lifesciences I, L.P.
10% Owner -
|
0 | 0 | |
| David D Davidar Director - [D] | 510 175 | 510 175 | |
| John A DeFord Director - [D] | 15 578 | 15 578 | |
| David M Demski President, CEO, Director - [D] [O] | 0 | 0 | |
| Robert Andrew Douglas Director - [D] | 2 005 | 2 005 | |
|
Goldman Sachs Pep 2004 Advisors, L.l.c.
10% Owner -
|
7 643 526 | 7 643 526 | |
| Kelly Huller EVP, GC, Corporate Secretary - [O] | 0 | 0 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Kyle Kline Senior Vice President, CFO - [O] | 0 | 0 | |
| Robert Liptak - | 26 159 | 26 159 | |
| Dan Lemaitre Director - [D] | 0 | 0 | |
|
Multi-strategy Holdings Offshore Advisors, Inc.
10% Owner -
|
7 643 526 | 7 643 526 | |
| A Brett Murphy Group President, Commerical Op - [O] | 35 217 | 35 217 | |
| Leslie V Norwalk Director - [D] | 10 419 | 10 419 | |
|
David C Paul
Executive Chairman, Director, 10% Owner -
[D]
[O]
|
60 417 | 60 417 | |
| Steven Payne Chief Accounting Officer - [O] | 0 | 0 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Keith W Pfeil COO, CFO - [O] | 0 | 0 | |
| Ann D Rhoads Director - [D] | 15 384 | 15 384 | |
| Daniel T Scavilla President, CEO, Director - [D] [O] | 0 | 0 | |
| Eric Schwartz Senior VP and General Counsel - [O] | 0 | 0 | |
| James R Tobin Director - [D] | 0 | 0 | |
| Kurt Wheeler - | 44 319 | 44 319 | |
| Anthony L Williams President - [O] | 0 | 0 | |
| Dan Wolterman Director - [D] | 24 025 | 24 025 | |
| Stephen T Zarrilli Director - [D] | 0 | 0 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i GMED / Globus Medical, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
| Handelsdatum | Insider | Rapporterade aktier |
Rapporterat pris |
Justerade aktier |
Justerat pris |
Kostnadsbasis | Dagar til Max |
Pris vid Max |
Maximal vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insynsperson |
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i GMED / Globus Medical, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-25 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 94,5000 | −20 000 | −1 890 | 0 | ||||
| 2026-02-27 | 2026-02-25 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 43,5800 | 20 000 | 872 | 20 000 | ||||
| 2026-02-17 | 2026-02-12 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 87,6700 | −10 000 | −877 | 0 | ||||
| 2026-02-17 | 2026-02-12 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 45,6400 | 10 000 | 456 | 10 000 | ||||
| 2026-01-12 | 2026-01-08 | 4 | Kline Kyle | GMED | Class A Common Stock | D | 101,1000 | −3 594 | −363 | 0 | ||||
| 2026-01-12 | 2026-01-08 | 4 | Kline Kyle | GMED | Class A Common Stock | D | 51,8700 | 3 594 | 186 | 3 594 | ||||
| 2026-01-12 | 2026-01-08 | 4 | Norwalk Leslie V | GMED | Class A Common Stock | D | 101,1000 | −2 000 | −202 | 10 419 | ||||
| 2026-01-05 | 2025-01-02 | 4 | Davidar David D | GMED | Class A Common Stock | D | −6 100 | 510 175 | ||||||
| 2025-12-16 | 2025-12-12 | 4 | Norwalk Leslie V | GMED | Class A Common Stock | D | 88,8500 | −4 000 | −355 | 12 419 | ||||
| 2025-12-10 | 2025-12-08 | 4 | Paul David C | GMED | Class A Common Stock | D | 25,5200 | 34 375 | 877 | 60 417 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Kline Kyle | GMED | Class A Common Stock | D | 90,0000 | −18 542 | −1 669 | 0 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Kline Kyle | GMED | Class A Common Stock | D | 63,6800 | 4 896 | 312 | 18 542 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Kline Kyle | GMED | Class A Common Stock | D | 64,4400 | 5 000 | 322 | 13 646 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Kline Kyle | GMED | Class A Common Stock | D | 56,4300 | 5 000 | 282 | 8 646 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Kline Kyle | GMED | Class A Common Stock | D | 53,1400 | 3 646 | 194 | 3 646 | ||||
| 2025-11-28 | 2025-11-25 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 90,0000 | −7 500 | −675 | 0 | ||||
| 2025-11-28 | 2025-11-25 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 25,9600 | 7 500 | 195 | 7 500 | ||||
| 2025-11-13 | 2025-11-12 | 4 | Davidar David D | GMED | Class A Common Stock | D | 86,0002 | −25 000 | −2 150 | 516 275 | ||||
| 2025-11-13 | 2025-11-12 | 4 | Davidar David D | GMED | Class A Common Stock | D | 25,5200 | 25 000 | 638 | 541 275 | ||||
| 2025-11-13 | 2025-11-11 | 4 | ZARRILLI STEPHEN T | GMED | Class A Common Stock | D | 84,2903 | −25 000 | −2 107 | 0 | ||||
| 2025-11-13 | 2025-11-11 | 4 | ZARRILLI STEPHEN T | GMED | Class A Common Stock | D | 44,1400 | 25 000 | 1 104 | 25 000 | ||||
| 2025-11-10 | 2025-11-10 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 85,0000 | −2 000 | −170 | 15 384 | ||||
| 2025-11-10 | 2025-11-07 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 81,0000 | −8 000 | −648 | 17 384 | ||||
| 2025-09-16 | 2025-09-15 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 58,4600 | −10 000 | −585 | 25 384 | ||||
| 2025-03-04 | 2025-02-28 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 78,6800 | −7 500 | −590 | 35 384 | ||||
| 2025-01-14 | 2025-01-10 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 89,1700 | −1 666 | −149 | 0 | ||||
| 2025-01-14 | 2025-01-10 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 88,1700 | −12 501 | −1 102 | 1 666 | ||||
| 2025-01-14 | 2025-01-10 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 53,2700 | 8 334 | 444 | 14 167 | ||||
| 2025-01-14 | 2025-01-10 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 49,6500 | 5 833 | 290 | 5 833 | ||||
| 2024-12-04 | 2024-12-02 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 87,0006 | −2 500 | −218 | 0 | ||||
| 2024-12-04 | 2024-12-02 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 24,2100 | 2 500 | 61 | 2 500 | ||||
| 2024-11-25 | 2024-11-22 | 4 | Davidar David D By Davidar Family Irrevocable Trust | GMED | Class A Common Stock | I | 85,0037 | −6 746 | −573 | 165 967 | ||||
| 2024-11-25 | 2024-11-22 | 4 | Davidar David D | GMED | Class A Common Stock | D | 85,0037 | −6 766 | −575 | 516 275 | ||||
| 2024-11-25 | 2024-11-21 | 4 | Davidar David D By Davidar Family Irrevocable Trust | GMED | Class A Common Stock | I | 85,0000 | −13 254 | −1 127 | 172 713 | ||||
| 2024-11-25 | 2024-11-21 | 4 | Davidar David D | GMED | Class A Common Stock | D | 85,0000 | −13 234 | −1 125 | 523 041 | ||||
| 2024-11-25 | 2024-11-22 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 85,0166 | −1 097 | −93 | 0 | ||||
| 2024-11-25 | 2024-11-22 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 65,0500 | 1 097 | 71 | 1 097 | ||||
| 2024-11-25 | 2024-11-21 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 85,0000 | −13 278 | −1 129 | 0 | ||||
| 2024-11-25 | 2024-11-21 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 65,0500 | 13 278 | 864 | 13 278 | ||||
| 2024-11-25 | 2024-11-21 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 85,0000 | −130 000 | −11 050 | 0 | ||||
| 2024-11-25 | 2024-11-21 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 43,5800 | 80 000 | 3 486 | 130 000 | ||||
| 2024-11-25 | 2024-11-21 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 43,7700 | 50 000 | 2 188 | 50 000 | ||||
| 2024-11-20 | 2024-11-15 | 4 | Paul David C | GMED | Class A Common Stock | D | 24,1000 | 26 042 | 628 | 26 042 | ||||
| 2024-11-08 | 2024-11-06 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 80,0200 | −60 000 | −4 801 | 0 | ||||
| 2024-11-08 | 2024-11-06 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 43,7700 | 30 000 | 1 313 | 60 000 | ||||
| 2024-11-08 | 2024-11-06 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 26,2700 | 30 000 | 788 | 30 000 | ||||
| 2024-11-08 | 2024-11-06 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 82,0000 | −2 500 | −205 | 0 | ||||
| 2024-11-08 | 2024-11-06 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 80,0200 | −2 500 | −200 | 2 500 | ||||
| 2024-11-08 | 2024-11-06 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 24,2100 | 5 000 | 121 | 5 000 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 75,0199 | −7 500 | −563 | |||||
| 2024-10-18 | 2024-10-16 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 25,8000 | 7 500 | 194 | 7 500 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Davidar David D By Davidar Family Irrevocable Trust | GMED | Class A Common Stock | I | 75,0305 | −20 000 | −1 501 | 185 967 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Davidar David D | GMED | Class A Common Stock | D | 75,0401 | −30 000 | −2 251 | 536 275 | ||||
| 2024-09-17 | 2024-09-13 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 70,3600 | −15 000 | −1 055 | 42 884 | ||||
| 2024-09-17 | 2024-09-13 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 25,5200 | 20 000 | 510 | 57 884 | ||||
| 2024-09-17 | 2024-09-13 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 24,1000 | 15 000 | 362 | 37 884 | ||||
| 2024-09-17 | 2024-09-13 | 4 | Davidar David D | GMED | Class A Common Stock | D | 70,4600 | −25 000 | −1 761 | 566 275 | ||||
| 2024-09-17 | 2024-09-13 | 4 | Davidar David D | GMED | Class A Common Stock | D | 25,5200 | 25 000 | 638 | 591 275 | ||||
| 2024-07-15 | 2024-07-11 | 4 | Norwalk Leslie V | GMED | Class A Common Stock | D | 70,0000 | −1 000 | −70 | 16 419 | ||||
| 2024-05-14 | 2024-05-10 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 64,6133 | −63 300 | −4 090 | 0 | ||||
| 2024-05-14 | 2024-05-10 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 53,2700 | 17 500 | 932 | 63 300 | ||||
| 2024-05-14 | 2024-05-10 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 43,5800 | 17 500 | 763 | 45 800 | ||||
| 2024-05-14 | 2024-05-10 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 43,7700 | 17 500 | 766 | 28 300 | ||||
| 2024-05-10 | 2024-05-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 65,0000 | −20 000 | −1 300 | 566 275 | ||||
| 2024-03-19 | 2024-03-15 | 4 | Norwalk Leslie V | GMED | Class A Common Stock | D | 51,9900 | −10 590 | −551 | 17 419 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 54,5300 | −3 115 | −170 | 0 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 53,7900 | −4 385 | −236 | 3 115 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 24,9000 | 7 500 | 187 | 7 500 | ||||
| 2024-01-25 | 2024-01-18 | 4 | Davidar David D | GMED | Class A Common Stock | D | −8 000 | 586 275 | ||||||
| 2023-09-06 | 2023-09-01 | 4/A | DeFord John A | GMED | Class A Common Stock | D | 15 578 | 15 578 | ||||||
| 2023-09-06 | 2023-09-01 | 4 | Wolterman Dan | GMED | Class A Common Stock | D | 24 025 | 24 025 | ||||||
| 2023-09-06 | 2023-09-01 | 4 | Norwalk Leslie V | GMED | Class A Common Stock | D | 25 688 | 28 009 | ||||||
| 2023-09-06 | 2023-09-01 | 4 | Norwalk Leslie V | GMED | Class A Common Stock | D | 2 321 | 2 321 | ||||||
| 2023-09-06 | 2023-09-01 | 4 | DeFord John A | GMED | Class A Common Stock | D | 15 578 | 15 578 | ||||||
| 2023-05-17 | 2023-05-15 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 56,9845 | −43 450 | −2 476 | 10 800 | ||||
| 2023-05-17 | 2023-05-15 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 26,2700 | 17 500 | 460 | 54 250 | ||||
| 2023-05-17 | 2023-05-15 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 25,5200 | 14 000 | 357 | 36 750 | ||||
| 2023-05-17 | 2023-05-15 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 24,1000 | 10 500 | 253 | 22 750 | ||||
| 2023-05-17 | 2023-05-15 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 23,9500 | 1 450 | 35 | 12 250 | ||||
| 2023-02-13 | 2023-02-09 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 23,9500 | 5 550 | 133 | 10 800 | ||||
| 2023-02-06 | 2023-02-02 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 77,5680 | −29 167 | −2 262 | 0 | ||||
| 2023-02-06 | 2023-02-02 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 53,2700 | 15 000 | 799 | 29 167 | ||||
| 2023-02-06 | 2023-02-02 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 49,6500 | 14 167 | 703 | 14 167 | ||||
| 2023-02-06 | 2021-08-19 | 4/A | Pfeil Keith W | GMED | Class A Common Stock | D | 76,1300 | −833 | −63 | 0 | ||||
| 2023-02-06 | 2021-08-19 | 4/A | Pfeil Keith W | GMED | Class A Common Stock | D | 49,6500 | 833 | 41 | 833 | ||||
| 2023-01-30 | 2023-01-27 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 12,5900 | 7 500 | 94 | 22 884 | ||||
| 2023-01-30 | 2023-01-27 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 12,5900 | 5 250 | 66 | 5 250 | ||||
| 2023-01-18 | 2022-03-14 | 4 | Davidar David D | GMED | Class A Common Stock | D | −7 000 | 594 275 | ||||||
| 2022-12-05 | 2022-12-01 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 75,0001 | −7 500 | −563 | 0 | ||||
| 2022-12-05 | 2022-12-01 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 12,5900 | 7 500 | 94 | 7 500 | ||||
| 2022-04-22 | 2022-04-21 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 79,00 | 60 000 | 60 000 | |||||
| 2022-04-21 | 2022-04-19 | 4 | Davidar David D | GMED | Class A Common Stock | D | 78,0340 | −31 500 | −2 458 | 601 275 | ||||
| 2022-04-11 | 2022-04-08 | 4 | Huller Kelly | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −2 500 | 0 | |||||
| 2022-04-11 | 2022-04-08 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 75,5850 | −2 500 | −189 | 0 | ||||
| 2022-04-11 | 2022-04-08 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 15,3400 | 2 500 | 38 | 2 500 | ||||
| 2022-03-17 | 2022-03-15 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | −3 542 | 21 458 | |||||
| 2022-03-17 | 2022-03-15 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | −5 308 | 5 208 | |||||
| 2022-03-17 | 2022-03-15 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 65,4710 | −8 850 | −579 | 0 | ||||
| 2022-03-17 | 2022-03-15 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 53,2700 | 3 542 | 189 | 8 850 | ||||
| 2022-03-17 | 2022-03-15 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 43,5800 | 5 308 | 231 | 5 308 | ||||
| 2022-03-10 | 2022-03-10 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | −10 000 | 10 516 | |||||
| 2022-03-10 | 2022-03-10 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 70,0398 | −10 000 | −700 | 0 | ||||
| 2022-03-10 | 2022-03-10 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 43,5800 | 10 000 | 436 | 10 000 | ||||
| 2022-03-10 | 2022-03-08 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | −4 484 | 20 516 | |||||
| 2022-03-10 | 2022-03-08 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 72,0000 | −4 484 | −323 | 0 | ||||
| 2022-03-10 | 2022-03-08 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 43,5800 | 4 484 | 195 | 4 484 | ||||
| 2022-02-07 | 2021-09-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | −2 000 | 632 775 | ||||||
| 2022-01-31 | 2022-01-27 | 4 | Douglas Robert Andrew | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 15 000 | 15 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | ZARRILLI STEPHEN T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 15 000 | 15 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 15 000 | 15 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 15 000 | 15 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 15 000 | 15 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 15 000 | 15 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | Huller Kelly | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 30 000 | 30 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 40 000 | 40 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 40 000 | 40 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 150 000 | 150 000 | |||||
| 2022-01-31 | 2022-01-27 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 63,68 | 75 000 | 75 000 | |||||
| 2021-08-23 | 2021-08-19 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | −833 | 23 334 | |||||
| 2021-08-23 | 2021-08-19 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 76,1300 | −833 | −63 | 0 | ||||
| 2021-08-23 | 2021-08-19 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 53,2700 | 833 | 44 | 833 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | −833 | 24 167 | |||||
| 2021-08-03 | 2021-08-02 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 83,2400 | −833 | −69 | 0 | ||||
| 2021-08-03 | 2021-08-02 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 53,2700 | 833 | 44 | 833 | ||||
| 2021-07-20 | 2021-07-19 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 49,65 | −834 | 20 833 | |||||
| 2021-07-20 | 2021-07-19 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 78,2500 | −834 | −65 | 0 | ||||
| 2021-07-20 | 2021-07-19 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 49,6500 | 834 | 41 | 834 | ||||
| 2021-07-07 | 2021-07-02 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to buy Class A Common Stock) | D | 25,52 | −50 000 | 30 000 | |||||
| 2021-07-07 | 2021-07-02 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −50 000 | 30 000 | |||||
| 2021-07-07 | 2021-07-02 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 78,9700 | −400 | −32 | 0 | ||||
| 2021-07-07 | 2021-07-02 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 78,4100 | −99 600 | −7 810 | 400 | ||||
| 2021-07-07 | 2021-07-02 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 26,2700 | 50 000 | 1 314 | 100 000 | ||||
| 2021-07-07 | 2021-07-02 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 25,5200 | 50 000 | 1 276 | 50 000 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | −833 | 25 000 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 77,4300 | −833 | −64 | 0 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 53,2700 | 833 | 44 | 833 | ||||
| 2021-06-28 | 2021-06-25 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | −14 167 | 25 833 | |||||
| 2021-06-28 | 2021-06-25 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 49,65 | −13 312 | 21 667 | |||||
| 2021-06-28 | 2021-06-25 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 75,0400 | −27 479 | −2 062 | 0 | ||||
| 2021-06-28 | 2021-06-25 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 53,2700 | 14 167 | 755 | 14 167 | ||||
| 2021-06-28 | 2021-06-25 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 49,6500 | 13 312 | 661 | 13 312 | ||||
| 2021-05-12 | 2021-05-10 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | −25 000 | 0 | |||||
| 2021-05-12 | 2021-05-10 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 71,9600 | −25 000 | −1 799 | 0 | ||||
| 2021-05-12 | 2021-05-10 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 43,7700 | 25 000 | 1 094 | 25 000 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 49,65 | −5 021 | 34 979 | |||||
| 2021-05-07 | 2021-05-05 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 75,0000 | −5 021 | −377 | 0 | ||||
| 2021-05-07 | 2021-05-05 | 4 | Pfeil Keith W | GMED | Class A Common Stock | D | 49,6500 | 5 021 | 249 | 5 021 | ||||
| 2021-04-27 | 2021-04-26 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 29,31 | −65 929 | 31 250 | |||||
| 2021-04-27 | 2021-04-26 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −78 334 | 0 | |||||
| 2021-04-27 | 2021-04-26 | 4 | Demski David M | GMED | Class A Common Stock | D | 71,5000 | −144 263 | −10 315 | 0 | ||||
| 2021-04-27 | 2021-04-26 | 4 | Demski David M | GMED | Class A Common Stock | D | 29,3100 | 65 929 | 1 932 | 144 263 | ||||
| 2021-04-27 | 2021-04-26 | 4 | Demski David M | GMED | Class A Common Stock | D | 26,2700 | 78 334 | 2 058 | 78 334 | ||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | −54 688 | 120 312 | |||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 29,31 | −22 821 | 97 179 | |||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | −21 875 | 65 625 | |||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | −21 875 | 65 625 | |||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Class A Common Stock | D | 71,5900 | −121 259 | −8 681 | 0 | ||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Class A Common Stock | D | 53,2700 | 54 688 | 2 913 | 121 259 | ||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Class A Common Stock | D | 29,3100 | 22 821 | 669 | 66 571 | ||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Class A Common Stock | D | 43,5800 | 21 875 | 953 | 43 750 | ||||
| 2021-04-27 | 2021-04-23 | 4 | Demski David M | GMED | Class A Common Stock | D | 43,7700 | 21 875 | 957 | 21 875 | ||||
| 2021-03-11 | 2021-03-09 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,28 | −15 384 | 0 | |||||
| 2021-03-11 | 2021-03-09 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 62,4700 | −15 384 | −961 | 0 | ||||
| 2021-03-11 | 2021-03-09 | 4 | Lemaitre Dan | GMED | Class A Common Stock | D | 11,2800 | 15 384 | 174 | 15 384 | ||||
| 2021-03-03 | 2021-03-01 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | −15 384 | 0 | |||||
| 2021-03-03 | 2021-03-01 | 4 | RHOADS ANN D | GMED | Class A Common Stock | D | 10,6600 | 15 384 | 164 | 15 384 | ||||
| 2021-01-19 | 2021-01-14 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 15 000 | 15 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 15 000 | 15 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 15 000 | 15 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | ZARRILLI STEPHEN T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 15 000 | 15 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 15 000 | 15 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Douglas Robert Andrew | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 15 000 | 15 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Huller Kelly | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 30 000 | 30 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 40 000 | 40 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 50 000 | 50 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 175 000 | 175 000 | |||||
| 2021-01-19 | 2021-01-14 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 65,05 | 100 000 | 100 000 | |||||
| 2020-12-29 | 2020-12-28 | 4 | Huller Kelly | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,28 | −2 000 | 0 | |||||
| 2020-12-29 | 2020-12-28 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 66,1500 | −2 000 | −132 | 0 | ||||
| 2020-12-29 | 2020-12-28 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 11,2800 | 2 000 | 23 | 2 000 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | −15 864 | 0 | |||||
| 2020-12-18 | 2020-12-17 | 4 | Demski David M | GMED | Class A Common Stock | D | 64,2000 | −164 719 | −10 575 | 0 | ||||
| 2020-12-18 | 2020-12-17 | 4 | Demski David M | GMED | Class A Common Stock | D | 24,1000 | 15 864 | 382 | 164 719 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | −7 053 | 15 864 | |||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | −31 137 | 0 | |||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −1 666 | 78 334 | |||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 29,31 | −6 250 | 120 000 | |||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | −3 125 | 87 500 | |||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | −3 125 | 87 500 | |||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Class A Common Stock | D | 64,2000 | −52 356 | −3 361 | 148 855 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Class A Common Stock | D | 24,1000 | 7 053 | 170 | 201 211 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Class A Common Stock | D | 25,5200 | 31 137 | 795 | 194 158 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Class A Common Stock | D | 26,2700 | 1 666 | 44 | 163 021 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Class A Common Stock | D | 29,3100 | 6 250 | 183 | 161 355 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Class A Common Stock | D | 43,5800 | 3 125 | 136 | 155 105 | ||||
| 2020-12-18 | 2020-12-16 | 4 | Demski David M | GMED | Class A Common Stock | D | 43,7700 | 3 125 | 137 | 151 980 | ||||
| 2020-12-18 | 2020-08-06 | 4/A | Demski David M | GMED | Class A Common Stock | D | 57,0200 | −165 000 | −9 408 | 148 855 | ||||
| 2020-12-18 | 2020-08-06 | 4/A | Demski David M | GMED | Class A Common Stock | D | 56,2400 | −68 100 | −3 830 | 313 855 | ||||
| 2020-12-18 | 2020-08-06 | 4/A | Demski David M | GMED | Class A Common Stock | D | 55,4200 | −96 900 | −5 370 | 381 955 | ||||
| 2020-12-18 | 2020-08-06 | 4/A | Demski David M | GMED | Class A Common Stock | D | 43,5800 | 59 375 | 2 588 | 478 855 | ||||
| 2020-12-18 | 2020-08-06 | 4/A | Demski David M | GMED | Class A Common Stock | D | 43,7700 | 96 875 | 4 240 | 419 480 | ||||
| 2020-12-18 | 2020-08-06 | 4/A | Demski David M | GMED | Class A Common Stock | D | 29,3100 | 173 750 | 5 093 | 322 605 | ||||
| 2020-11-27 | 2020-11-24 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 60,0000 | −10 000 | −600 | 205 967 | ||||
| 2020-11-27 | 2020-11-24 | 4 | Davidar David D | GMED | Class A Common Stock | D | 60,0000 | −32 000 | −1 920 | 634 775 | ||||
| 2020-09-03 | 2020-09-02 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −5 600 | 0 | |||||
| 2020-09-03 | 2020-09-02 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 56,8500 | −5 600 | −318 | 0 | ||||
| 2020-09-03 | 2020-09-02 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 26,2700 | 5 600 | 147 | 5 600 | ||||
| 2020-08-26 | 2020-08-25 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −17 400 | 5 600 | |||||
| 2020-08-26 | 2020-08-25 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 54,4000 | −17 400 | −947 | 0 | ||||
| 2020-08-26 | 2020-08-25 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 26,2700 | 17 400 | 457 | 17 400 | ||||
| 2020-08-25 | 2020-08-24 | 4 | Douglas Robert Andrew | GMED | Class A Common Stock | D | 53,8800 | 615 | 33 | 2 005 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Huller Kelly | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,28 | −12 000 | 2 000 | |||||
| 2020-08-10 | 2020-08-06 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 57,9000 | −3 000 | −174 | 0 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 55,9200 | −3 000 | −168 | 3 000 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 54,7800 | −6 000 | −329 | 6 000 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 11,2800 | 12 000 | 135 | 12 000 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | −59 375 | 90 625 | |||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | −96 875 | 53 125 | |||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 29,31 | −173 750 | 126 250 | |||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 57,0200 | −165 000 | −9 408 | 0 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 56,2400 | −68 100 | −3 830 | 165 000 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 55,4200 | −96 900 | −5 370 | 233 100 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 43,5800 | 59 375 | 2 588 | 330 000 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 43,7700 | 96 875 | 4 240 | 270 625 | ||||
| 2020-08-10 | 2020-08-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 29,3100 | 173 750 | 5 093 | 173 750 | ||||
| 2020-07-24 | 2020-07-22 | 4 | Douglas Robert Andrew | GMED | Class A Common Stock | D | 47,7500 | 690 | 33 | 1 390 | ||||
| 2020-06-24 | 2020-06-22 | 4 | Douglas Robert Andrew | GMED | Class A Common Stock | D | 48,2000 | 700 | 34 | 700 | ||||
| 2020-06-15 | 2020-06-11 | 4 | Huller Kelly | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,28 | −9 076 | 14 000 | |||||
| 2020-06-15 | 2020-06-11 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 51,0000 | −9 076 | −463 | 0 | ||||
| 2020-06-15 | 2020-06-11 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 11,2800 | 9 076 | 102 | 9 076 | ||||
| 2020-05-26 | 2020-05-21 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | −68 750 | 50 000 | |||||
| 2020-05-26 | 2020-05-21 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,40 | −31 250 | 0 | |||||
| 2020-05-26 | 2020-05-21 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 55,0900 | −100 000 | −5 509 | 0 | ||||
| 2020-05-26 | 2020-05-21 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 25,5200 | 68 750 | 1 754 | 100 000 | ||||
| 2020-05-26 | 2020-05-21 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 25,4000 | 31 250 | 794 | 31 250 | ||||
| 2020-01-24 | 2020-01-22 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 100 000 | 100 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 80 000 | 80 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | Huller Kelly | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 40 000 | 40 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 40 000 | 40 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 25 000 | 25 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 25 000 | 25 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 25 000 | 25 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 25 000 | 25 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | ZARRILLI STEPHEN T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 25 000 | 25 000 | |||||
| 2020-01-24 | 2020-01-22 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 53,27 | 175 000 | 175 000 | |||||
| 2019-12-19 | 2019-12-17 | 4 | Huller Kelly | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,86 | −3 076 | 0 | |||||
| 2019-12-19 | 2019-12-17 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 58,9000 | −6 460 | −380 | 0 | ||||
| 2019-12-19 | 2019-12-17 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 11,8600 | 3 076 | 36 | 3 076 | ||||
| 2019-12-17 | 3 | Douglas Robert Andrew | GMED | No securities are beneficially owned | D | 0 | ||||||||
| 2019-12-17 | 2019-12-11 | 4 | Douglas Robert Andrew | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 56,89 | 25 000 | 25 000 | |||||
| 2019-11-12 | 2019-11-07 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 54,0400 | −10 000 | −540 | 215 967 | ||||
| 2019-11-12 | 2019-11-07 | 4 | Davidar David D | GMED | Class A Common Stock | D | 54,0000 | −38 000 | −2 052 | 666 775 | ||||
| 2019-11-12 | 2019-11-07 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 55,9000 | −3 000 | −168 | 3 384 | ||||
| 2019-11-04 | 2019-11-01 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 52,9000 | −3 000 | −159 | 6 384 | ||||
| 2019-09-05 | 2019-09-03 | 4 | Pfeil Keith W | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 49,65 | 40 000 | 40 000 | |||||
| 2019-08-29 | 2019-08-02 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 49,9000 | −3 000 | −150 | 9 384 | ||||
| 2019-08-26 | 3 | Pfeil Keith W | GMED | No securities are beneficially owned | D | 0 | ||||||||
| 2019-08-19 | 2019-08-16 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | −50 000 | 0 | |||||
| 2019-08-19 | 2019-08-16 | 4 | Davidar David D | GMED | Class A Common Stock | D | 49,3301 | −50 000 | −2 467 | 704 775 | ||||
| 2019-08-19 | 2019-08-16 | 4 | Davidar David D | GMED | Class A Common Stock | D | 24,1000 | 50 000 | 1 205 | 754 775 | ||||
| 2019-05-03 | 3 | ZARRILLI STEPHEN T | GMED | No securities are beneficially owned | D | 0 | ||||||||
| 2019-05-03 | 2019-05-01 | 4 | ZARRILLI STEPHEN T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 44,14 | 25 000 | 25 000 | |||||
| 2019-04-01 | 2019-03-28 | 4 | Huller Kelly | GMED | Class A Common Stock | D | 48,5900 | −3 000 | −146 | 12 384 | ||||
| 2019-03-13 | 2019-03-12 | 4 | Davidar David D | GMED | Class A Common Stock | D | −5 000 | 704 775 | ||||||
| 2019-03-07 | 2019-03-07 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −37 826 | 36 667 | |||||
| 2019-03-07 | 2019-03-07 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 46,0100 | −37 826 | −1 740 | 0 | ||||
| 2019-03-07 | 2019-03-07 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 26,2700 | 37 826 | 994 | 37 826 | ||||
| 2019-03-07 | 2019-03-06 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −5 507 | 74 493 | |||||
| 2019-03-07 | 2019-03-06 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | −2 879 | 56 667 | |||||
| 2019-03-07 | 2019-03-06 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 46,1400 | −8 386 | −387 | 0 | ||||
| 2019-03-07 | 2019-03-06 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 26,2700 | 5 507 | 145 | 8 386 | ||||
| 2019-03-07 | 2019-03-06 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 43,7700 | 2 879 | 126 | 2 879 | ||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | −8 333 | 0 | |||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | −20 454 | 59 546 | |||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | −47 500 | 12 500 | |||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,65 | −89 583 | 10 417 | |||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 47,0500 | −165 870 | −7 804 | 0 | ||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 24,1000 | 8 333 | 201 | 165 870 | ||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 43,7700 | 20 454 | 895 | 157 537 | ||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 25,5200 | 47 500 | 1 212 | 137 083 | ||||
| 2019-03-07 | 2019-03-05 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 25,6500 | 89 583 | 2 298 | 89 583 | ||||
| 2019-03-06 | 3 | Huller Kelly | GMED | Class A Common Stock | D | 30 768 | ||||||||
| 2019-03-06 | 3 | Huller Kelly | GMED | Class A Common Stock | D | 30 768 | ||||||||
| 2019-03-06 | 3 | Huller Kelly | GMED | Class A Common Stock | D | 30 768 | ||||||||
| 2019-02-28 | 2019-02-28 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −2 000 | 23 000 | |||||
| 2019-02-28 | 2019-02-28 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | −20 000 | 0 | |||||
| 2019-02-28 | 2019-02-28 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,75 | −6 100 | 0 | |||||
| 2019-02-28 | 2019-02-28 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 47,0400 | −9 300 | −437 | 0 | ||||
| 2019-02-28 | 2019-02-28 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 48,1000 | −18 800 | −904 | 9 300 | ||||
| 2019-02-28 | 2019-02-28 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 26,2700 | 2 000 | 53 | 28 100 | ||||
| 2019-02-28 | 2019-02-28 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 25,5200 | 20 000 | 510 | 26 100 | ||||
| 2019-02-28 | 2019-02-28 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 24,7500 | 6 100 | 151 | 6 100 | ||||
| 2019-02-28 | 2019-02-26 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,75 | −8 900 | 6 100 | |||||
| 2019-02-28 | 2019-02-26 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 47,9100 | −400 | −19 | 0 | ||||
| 2019-02-28 | 2019-02-26 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 47,0600 | −8 500 | −400 | 400 | ||||
| 2019-02-28 | 2019-02-26 | 4 | TOBIN JAMES R | GMED | Class A Common Stock | D | 24,7500 | 8 900 | 220 | 8 900 | ||||
| 2019-02-11 | 2019-01-22 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 25 000 | 25 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 80 000 | 80 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 150 000 | 150 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 25 000 | 25 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 25 000 | 25 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 100 000 | 100 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 80 000 | 80 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 25 000 | 25 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 25 000 | 25 000 | |||||
| 2019-02-11 | 2019-01-22 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,58 | 25 000 | 25 000 | |||||
| 2019-02-11 | 2019-02-01 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,87 | 7 500 | 7 500 | |||||
| 2018-10-30 | 2018-09-26 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 12,59 | −3 000 | 0 | |||||
| 2018-10-30 | 2018-09-26 | 4 | Payne Steven | GMED | Class A Common Stock | D | 56,0000 | −3 000 | −168 | 0 | ||||
| 2018-10-30 | 2018-09-26 | 4 | Payne Steven | GMED | Class A Common Stock | D | 12,5900 | 3 000 | 38 | 3 000 | ||||
| 2018-09-26 | 2018-09-25 | 4 | Paul David C | GMED | Class B Common Stock | D | −748 845 | 20 867 524 | ||||||
| 2018-09-26 | 2018-09-25 | 4 | Paul David C | GMED | Class A Common Stock | D | 54,6964 | −748 845 | −40 959 | 0 | ||||
| 2018-09-26 | 2018-09-25 | 4 | Paul David C | GMED | Class A Common Stock | D | 748 845 | 748 845 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C | GMED | Class B Common Stock | D | −101 320 | 21 616 369 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C By Sonali Paul Children's Trust | GMED | Class B Common Stock | I | −298 647 | 0 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C By David C. Paul Children's Trust | GMED | Class B Common Stock | I | −298 647 | 0 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C | GMED | Class A Common Stock | D | 54,0126 | −101 320 | −5 473 | 0 | ||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C | GMED | Class A Common Stock | D | 101 320 | 101 320 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C By Sonali Paul Children's Trust | GMED | Class A Common Stock | I | 54,0126 | −298 647 | −16 131 | 0 | ||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C By David C. Paul Children's Trust | GMED | Class A Common Stock | I | 54,0126 | −298 647 | −16 131 | 0 | ||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C By Sonali Paul Children's Trust | GMED | Class A Common Stock | I | 298 647 | 298 647 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C By David C. Paul Children's Trust | GMED | Class A Common Stock | I | 298 647 | 298 647 | ||||||
| 2018-09-26 | 2018-09-24 | 4 | Paul David C | GMED | Class A Common Stock | D | 54,0126 | −605 871 | −32 725 | 0 | ||||
| 2018-07-19 | 2018-07-17 | 4 | Paul David C | GMED | Class A Common Stock | D | 52,9500 | −6 841 | −362 | 605 871 | ||||
| 2018-06-27 | 2018-06-25 | 4 | Schwartz Eric | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,98 | −10 000 | 41 000 | |||||
| 2018-06-27 | 2018-06-25 | 4 | Schwartz Eric | GMED | Class A Common Stock | D | 54,5940 | −1 556 | −85 | 0 | ||||
| 2018-06-27 | 2018-06-25 | 4 | Schwartz Eric | GMED | Class A Common Stock | D | 53,6380 | −8 444 | −453 | 1 556 | ||||
| 2018-06-27 | 2018-06-25 | 4 | Schwartz Eric | GMED | Class A Common Stock | D | 24,9800 | 10 000 | 250 | 10 000 | ||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | −41 667 | 8 333 | |||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,42 | −40 000 | 0 | |||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | −30 000 | 0 | |||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | −10 000 | 0 | |||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 56,8720 | −1 400 | −80 | 0 | ||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 56,1353 | −120 267 | −6 751 | 1 400 | ||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 24,1000 | 41 667 | 1 004 | 121 667 | ||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 24,4200 | 40 000 | 977 | 80 000 | ||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 23,9500 | 30 000 | 718 | 40 000 | ||||
| 2018-06-13 | 2018-06-11 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 13,0400 | 10 000 | 130 | 10 000 | ||||
| 2018-06-04 | 2018-05-31 | 4 | Payne Steven | GMED | Class A Common Stock | D | 55,8096 | −20 771 | −1 159 | 0 | ||||
| 2018-04-30 | 2018-04-30 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8053 | −72 938 | −3 779 | 612 712 | ||||
| 2018-04-30 | 2018-04-27 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,7831 | −29 066 | −1 505 | 685 650 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | −43 750 | 106 250 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | −40 625 | 34 375 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | −98 958 | 26 042 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | −60 000 | 0 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | −48 000 | 0 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −15 000 | 0 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | −18 461 | 0 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | −18 461 | 0 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,86 | −18 461 | 0 | |||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −363 284 | −18 821 | 714 716 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −43 750 | −2 267 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 26,2700 | 43 750 | 1 149 | 1 121 750 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −40 625 | −2 105 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 25,5200 | 40 625 | 1 037 | 1 118 625 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −98 958 | −5 127 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 24,1000 | 98 958 | 2 385 | 1 176 958 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −60 000 | −3 108 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 23,9500 | 60 000 | 1 437 | 1 138 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −48 000 | −2 487 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 13,0400 | 48 000 | 626 | 1 126 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −15 000 | −777 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 15,3400 | 15 000 | 230 | 1 093 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −18 461 | −956 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −18 461 | −956 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 51,8068 | −18 461 | −956 | 1 078 000 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 10,6600 | 18 461 | 197 | 1 096 461 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 11,8625 | 18 461 | 219 | 1 096 461 | ||||
| 2018-04-30 | 2018-04-26 | 4 | Paul David C | GMED | Class A Common Stock | D | 4,8800 | 18 461 | 90 | 1 096 461 | ||||
| 2018-04-20 | 2018-04-19 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | −28 863 | 31 137 | |||||
| 2018-04-20 | 2018-04-19 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | −68 184 | 22 917 | |||||
| 2018-04-20 | 2018-04-19 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0000 | −28 863 | −1 472 | 148 855 | ||||
| 2018-04-20 | 2018-04-19 | 4 | Demski David M | GMED | Class A Common Stock | D | 25,5200 | 28 863 | 737 | 177 718 | ||||
| 2018-04-20 | 2018-04-19 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0000 | −68 184 | −3 477 | 148 855 | ||||
| 2018-04-20 | 2018-04-19 | 4 | Demski David M | GMED | Class A Common Stock | D | 24,1000 | 68 184 | 1 643 | 217 039 | ||||
| 2018-04-20 | 2018-04-18 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | −8 899 | 91 101 | |||||
| 2018-04-20 | 2018-04-18 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | −43 163 | 0 | |||||
| 2018-04-20 | 2018-04-18 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0001 | −8 899 | −454 | 148 855 | ||||
| 2018-04-20 | 2018-04-18 | 4 | Demski David M | GMED | Class A Common Stock | D | 24,1000 | 8 899 | 214 | 157 754 | ||||
| 2018-04-20 | 2018-04-18 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0001 | −43 163 | −2 201 | 148 855 | ||||
| 2018-04-20 | 2018-04-18 | 4 | Demski David M | GMED | Class A Common Stock | D | 23,9500 | 43 163 | 1 034 | 192 018 | ||||
| 2018-04-16 | 2018-04-13 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | −3 043 | 43 163 | |||||
| 2018-04-16 | 2018-04-13 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0000 | −3 043 | −155 | 148 855 | ||||
| 2018-04-16 | 2018-04-13 | 4 | Demski David M | GMED | Class A Common Stock | D | 23,9500 | 3 043 | 73 | 151 898 | ||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | −8 794 | 46 206 | |||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −6 875 | 0 | |||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | −28 333 | 0 | |||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | −3 846 | 0 | |||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0000 | −8 794 | −448 | 148 855 | ||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Class A Common Stock | D | 23,9500 | 8 794 | 211 | 157 649 | ||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0000 | −6 875 | −351 | 148 855 | ||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Class A Common Stock | D | 15,3400 | 6 875 | 105 | 155 730 | ||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0000 | −28 333 | −1 445 | 148 855 | ||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Class A Common Stock | D | 13,0400 | 28 333 | 369 | 177 188 | ||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Class A Common Stock | D | 51,0000 | −3 846 | −196 | 148 855 | ||||
| 2018-04-16 | 2018-04-12 | 4 | Demski David M | GMED | Class A Common Stock | D | 10,6600 | 3 846 | 41 | 152 701 | ||||
| 2018-04-11 | 2018-04-10 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | −31 250 | 118 750 | |||||
| 2018-04-11 | 2018-04-10 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,40 | −50 540 | 31 250 | |||||
| 2018-04-11 | 2018-04-10 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 50,0000 | −31 250 | −1 562 | 0 | ||||
| 2018-04-11 | 2018-04-10 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 25,5200 | 31 250 | 798 | 31 250 | ||||
| 2018-04-11 | 2018-04-10 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 50,0000 | −50 540 | −2 527 | 0 | ||||
| 2018-04-11 | 2018-04-10 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 25,4000 | 50 540 | 1 284 | 50 540 | ||||
| 2018-04-11 | 2018-04-09 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,40 | −18 210 | 81 790 | |||||
| 2018-04-11 | 2018-04-09 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 50,0017 | −18 210 | −911 | 0 | ||||
| 2018-04-11 | 2018-04-09 | 4 | Scavilla Daniel T | GMED | Class A Common Stock | D | 25,4000 | 18 210 | 463 | 18 210 | ||||
| 2018-03-30 | 2018-03-28 | 4 | Schwartz Eric | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,98 | −24 000 | 51 000 | |||||
| 2018-03-30 | 2018-03-28 | 4 | Schwartz Eric | GMED | Class A Common Stock | D | 50,0000 | −24 000 | −1 200 | 0 | ||||
| 2018-03-30 | 2018-03-28 | 4 | Schwartz Eric | GMED | Class A Common Stock | D | 24,9800 | 24 000 | 600 | 24 000 | ||||
| 2018-03-16 | 2018-03-14 | 4 | Davidar David D | GMED | Class A Common Stock | D | −24 000 | 709 775 | ||||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | −30 000 | 0 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | −25 000 | 0 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −15 000 | 0 | |||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 50,5003 | −30 000 | −1 515 | 733 775 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 23,9500 | 30 000 | 718 | 763 775 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 50,5003 | −25 000 | −1 263 | 733 775 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 13,0400 | 25 000 | 326 | 758 775 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 50,5003 | −15 000 | −758 | 733 775 | ||||
| 2018-03-12 | 2018-03-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 15,3400 | 15 000 | 230 | 748 775 | ||||
| 2018-02-06 | 2018-02-02 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 45,64 | 40 000 | 40 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 150 000 | 150 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 80 000 | 80 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 80 000 | 80 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | Schwartz Eric | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 40 000 | 40 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 7 500 | 7 500 | |||||
| 2018-01-24 | 2018-01-22 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 25 000 | 25 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 25 000 | 25 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 25 000 | 25 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 25 000 | 25 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 25 000 | 25 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 25 000 | 25 000 | |||||
| 2018-01-24 | 2018-01-22 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 43,77 | 100 000 | 100 000 | |||||
| 2017-12-18 | 2017-12-15 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | −3 076 | 0 | |||||
| 2017-12-18 | 2017-12-15 | 4 | Payne Steven | GMED | Class A Common Stock | D | 39,3019 | −3 076 | −121 | 20 771 | ||||
| 2017-12-18 | 2017-12-15 | 4 | Payne Steven | GMED | Class A Common Stock | D | 4,8800 | 3 076 | 15 | 23 847 | ||||
| 2017-12-14 | 2017-12-13 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | −15 000 | 10 000 | |||||
| 2017-12-14 | 2017-12-13 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 38,2994 | −15 000 | −574 | 0 | ||||
| 2017-12-14 | 2017-12-13 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 13,0400 | 15 000 | 196 | 15 000 | ||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | −18 461 | 0 | |||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | −18 461 | 0 | |||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,86 | −18 461 | 0 | |||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Class A Common Stock | D | 40,6550 | −18 461 | −751 | 733 775 | ||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Class A Common Stock | D | 40,6550 | −18 461 | −751 | 733 775 | ||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Class A Common Stock | D | 40,6550 | −18 461 | −751 | 733 775 | ||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Class A Common Stock | D | 10,6600 | 18 461 | 197 | 752 236 | ||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Class A Common Stock | D | 11,8600 | 18 461 | 219 | 752 236 | ||||
| 2017-12-06 | 2017-12-04 | 4 | Davidar David D | GMED | Class A Common Stock | D | 4,8800 | 18 461 | 90 | 752 236 | ||||
| 2017-11-13 | 2017-11-10 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 35,0000 | −14 551 | −509 | 35 217 | ||||
| 2017-11-13 | 2017-11-09 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 35,0000 | −51 449 | −1 801 | 49 768 | ||||
| 2017-09-07 | 2017-09-06 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 29,9935 | −15 000 | −450 | 101 217 | ||||
| 2017-08-30 | 2017-08-28 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 29,31 | 300 000 | 300 000 | |||||
| 2017-06-06 | 2017-06-05 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,28 | −16 153 | 0 | |||||
| 2017-06-06 | 2017-06-05 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 31,9410 | −16 153 | −516 | 0 | ||||
| 2017-06-06 | 2017-06-05 | 4 | Williams Anthony L | GMED | Class A Common Stock | D | 11,2800 | 16 153 | 182 | 16 153 | ||||
| 2017-02-01 | 2017-01-30 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 25 000 | 25 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 25 000 | 25 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 25 000 | 25 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 25 000 | 25 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 25 000 | 25 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 80 000 | 80 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 25 000 | 25 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 150 000 | 150 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 80 000 | 80 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 7 500 | 7 500 | |||||
| 2017-02-01 | 2017-01-30 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 80 000 | 80 000 | |||||
| 2017-02-01 | 2017-01-30 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 26,27 | 80 000 | 80 000 | |||||
| 2016-08-08 | 2016-08-05 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 2,93 | −32 992 | 0 | |||||
| 2016-08-08 | 2016-08-05 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 23,3936 | −32 992 | −772 | 116 217 | ||||
| 2016-08-08 | 2016-08-05 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 2,9300 | 32 992 | 97 | 149 209 | ||||
| 2016-08-08 | 2016-08-04 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 2,93 | −74 700 | 32 992 | |||||
| 2016-08-08 | 2016-08-04 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 23,3606 | −74 700 | −1 745 | 116 217 | ||||
| 2016-08-08 | 2016-08-04 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 2,9300 | 74 700 | 219 | 190 917 | ||||
| 2016-02-04 | 2015-09-15 | 4 | Davidar David D | GMED | Class A Common Stock | D | −20 000 | 733 775 | ||||||
| 2016-01-27 | 2016-01-25 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 20 000 | 20 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 20 000 | 20 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 20 000 | 20 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | Scavilla Daniel T | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 150 000 | 150 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 60 000 | 60 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 20 000 | 20 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 60 000 | 60 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 20 000 | 20 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 60 000 | 60 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 75 000 | 75 000 | |||||
| 2016-01-27 | 2016-01-25 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,52 | 50 000 | 50 000 | |||||
| 2016-01-06 | 2016-01-06 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −15 045 | 0 | |||||
| 2016-01-06 | 2016-01-06 | 4 | WHEELER KURT | GMED | Class A Common Stock | D | 27,5000 | −15 045 | −414 | 44 319 | ||||
| 2016-01-06 | 2016-01-06 | 4 | WHEELER KURT | GMED | Class A Common Stock | D | 15,3400 | 15 045 | 231 | 59 364 | ||||
| 2016-01-06 | 2016-01-04 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −255 | 15 045 | |||||
| 2016-01-06 | 2016-01-04 | 4 | WHEELER KURT | GMED | Class A Common Stock | D | 27,5000 | −255 | −7 | 44 319 | ||||
| 2016-01-06 | 2016-01-04 | 4 | WHEELER KURT | GMED | Class A Common Stock | D | 15,3400 | 255 | 4 | 44 574 | ||||
| 2016-01-06 | 2016-01-06 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −15 000 | 0 | |||||
| 2016-01-06 | 2016-01-06 | 4 | LIPTAK ROBERT | GMED | Class A Common Stock | D | 27,5000 | −15 000 | −412 | 26 159 | ||||
| 2016-01-06 | 2016-01-06 | 4 | LIPTAK ROBERT | GMED | Class A Common Stock | D | 15,3400 | 15 000 | 230 | 41 159 | ||||
| 2016-01-06 | 2016-01-04 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −300 | 15 000 | |||||
| 2016-01-06 | 2016-01-04 | 4 | LIPTAK ROBERT | GMED | Class A Common Stock | D | 27,5000 | −300 | −8 | 26 159 | ||||
| 2016-01-06 | 2016-01-04 | 4 | LIPTAK ROBERT | GMED | Class A Common Stock | D | 15,3400 | 300 | 5 | 26 459 | ||||
| 2015-11-18 | 2015-11-16 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 25,8000 | −5 000 | −129 | 116 217 | ||||
| 2015-09-01 | 3 | TOBIN JAMES R | GMED | No securities beneficially owned | D | 0 | ||||||||
| 2015-09-01 | 2015-08-28 | 4 | TOBIN JAMES R | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,75 | 15 000 | 15 000 | |||||
| 2015-08-03 | 2015-07-07 | 4 | Williams Anthony L | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,65 | 100 000 | 100 000 | |||||
| 2015-08-03 | 2015-07-07 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 25,65 | 100 000 | 100 000 | |||||
| 2015-06-01 | 2015-05-28 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,87 | −3 076 | 0 | |||||
| 2015-06-01 | 2015-05-28 | 4 | Payne Steven | GMED | Class A Common Stock | D | 25,9200 | −3 076 | −80 | 20 771 | ||||
| 2015-06-01 | 2015-05-28 | 4 | Payne Steven | GMED | Class A Common Stock | D | 11,8700 | 3 076 | 37 | 23 847 | ||||
| 2015-03-20 | 2015-03-19 | 4 | Paul David C | GMED | Class A Common Stock | D | 25,0000 | −494 921 | −12 373 | 1 078 000 | ||||
| 2015-03-20 | 2015-03-18 | 4 | Paul David C | GMED | Class A Common Stock | D | 25,0000 | −1 427 079 | −35 677 | 1 572 921 | ||||
| 2015-03-02 | 2015-01-20 | 4/A | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 125 000 | 125 000 | |||||
| 2015-03-02 | 2014-04-15 | 4/A | Paul David C | GMED | Class B Common Stock | D | −3 000 000 | 21 444 283 | ||||||
| 2015-03-02 | 2014-04-15 | 4/A | Paul David C | GMED | Class A Common Stock | D | 3 000 000 | 3 000 000 | ||||||
| 2015-03-02 | 2014-03-12 | 4/A | Paul David C | GMED | Class B Common Stock | D | −500 000 | 24 444 283 | ||||||
| 2015-03-02 | 2014-03-12 | 4/A | Paul David C | GMED | Class A Common Stock | D | −500 000 | 0 | ||||||
| 2015-03-02 | 2014-03-12 | 4/A | Paul David C | GMED | Class A Common Stock | D | 500 000 | 500 000 | ||||||
| 2015-03-02 | 2015-02-26 | 4 | Demski David M | GMED | Class A Common Stock | D | 26,0000 | −32 510 | −845 | 148 855 | ||||
| 2015-01-22 | 2015-01-20 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 15 000 | 15 000 | |||||
| 2015-01-22 | 2015-01-20 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 15 000 | 15 000 | |||||
| 2015-01-22 | 2015-01-20 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 100 000 | 100 000 | |||||
| 2015-01-22 | 2015-01-20 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 50 000 | 50 000 | |||||
| 2015-01-22 | 2015-01-20 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 22 500 | 22 500 | |||||
| 2015-01-22 | 2015-01-20 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 15 000 | 15 000 | |||||
| 2015-01-22 | 2015-01-20 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 15 000 | 15 000 | |||||
| 2015-01-22 | 2015-01-20 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 125 000 | 125 000 | |||||
| 2015-01-22 | 2014-04-15 | 4 | Paul David C | GMED | Class B Common Stock | D | −3 000 000 | 21 444 283 | ||||||
| 2015-01-22 | 2014-04-15 | 4 | Paul David C | GMED | Class A Common Stock | D | 3 000 000 | 3 000 000 | ||||||
| 2015-01-22 | 2014-03-12 | 4 | Paul David C | GMED | Class B Common Stock | D | −500 000 | 24 444 283 | ||||||
| 2015-01-22 | 2014-03-12 | 4 | Paul David C | GMED | Class A Common Stock | D | −500 000 | 0 | ||||||
| 2015-01-22 | 2014-03-12 | 4 | Paul David C | GMED | Class A Common Stock | D | 500 000 | 500 000 | ||||||
| 2015-01-22 | 2015-01-20 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 24,10 | 50 000 | 50 000 | |||||
| 2014-11-04 | 2014-10-31 | 4 | Davidar David D By Berachah Fondation | GMED | Class A Common Stock | I | 23,0600 | −38 500 | −888 | 0 | ||||
| 2014-11-04 | 2014-04-02 | 4 | Davidar David D By Berachah Fondation | GMED | Class A Common Stock | I | 38 500 | 38 500 | ||||||
| 2014-11-04 | 2014-04-02 | 4 | Davidar David D | GMED | Class A Common Stock | D | −38 500 | 753 775 | ||||||
| 2014-05-06 | 2014-05-02 | 4 | BARON RICHARD A | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,34 | −30 000 | 62 307 | |||||
| 2014-05-06 | 2014-05-02 | 4 | BARON RICHARD A | GMED | Class A Common Stock | D | 24,5200 | −30 000 | −736 | 0 | ||||
| 2014-05-06 | 2014-05-02 | 4 | BARON RICHARD A | GMED | Class A Common Stock | D | 10,3400 | 30 000 | 310 | 30 000 | ||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | −11 667 | 28 333 | |||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | −8 125 | 6 875 | |||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | −14 615 | 3 846 | |||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | −18 461 | 0 | |||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,87 | −18 461 | 0 | |||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 26,6100 | −1 500 | −40 | 181 365 | ||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 25,8300 | −269 829 | −6 970 | 182 865 | ||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 13,0400 | 11 667 | 152 | 452 694 | ||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 15,3400 | 8 125 | 125 | 441 027 | ||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 10,6600 | 14 615 | 156 | 432 902 | ||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 11,8700 | 18 461 | 219 | 418 287 | ||||
| 2014-03-10 | 2014-03-06 | 4 | Demski David M | GMED | Class A Common Stock | D | 4,8800 | 18 461 | 90 | 399 826 | ||||
| 2014-03-06 | 2014-03-04 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 25,0000 | −22 500 | −562 | 225 967 | ||||
| 2014-03-06 | 2014-03-04 | 4 | Davidar David D | GMED | Class A Common Stock | D | 25,0000 | −52 500 | −1 312 | 792 275 | ||||
| 2014-02-24 | 2014-02-20 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,57 | 7 500 | 7 500 | |||||
| 2014-02-20 | 2014-02-18 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 24,0000 | −22 500 | −540 | 248 467 | ||||
| 2014-02-20 | 2014-02-18 | 4 | Davidar David D | GMED | Class A Common Stock | D | 24,0000 | −52 500 | −1 260 | 844 775 | ||||
| 2014-01-27 | 2014-01-23 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | 10 000 | 10 000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | 10 000 | 10 000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | 10 000 | 10 000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | BARON RICHARD A | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | 30 000 | 30 000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | 10 000 | 10 000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock | D | 23,95 | 30 000 | 30 000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | 30 000 | 30 000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | 55 000 | 55 000 | |||||
| 2014-01-27 | 2014-01-23 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 23,95 | 60 000 | 60 000 | |||||
| 2014-01-16 | 2014-01-15 | 4 | Demski David M | GMED | Class A Common Stock | D | 20,5100 | −96 813 | −1 986 | 381 365 | ||||
| 2014-01-02 | 2013-12-31 | 4 | Demski David M | GMED | Class A Common Stock | D | 20,2500 | −3 187 | −65 | 478 178 | ||||
| 2013-12-20 | 2013-12-20 | 4 | Demski David M | GMED | Class A Common Stock | D | 19,7500 | −28 954 | −572 | 481 365 | ||||
| 2013-12-20 | 2013-12-19 | 4 | Demski David M | GMED | Class A Common Stock | D | 19,7500 | −19 412 | −383 | 510 319 | ||||
| 2013-12-20 | 2013-12-18 | 4 | Demski David M | GMED | Class A Common Stock | D | 19,7500 | −1 634 | −32 | 529 731 | ||||
| 2013-12-10 | 2013-12-06 | 4 | LIPTAK ROBERT | GMED | Class A Common Stock | D | 19,3600 | −25 000 | −484 | 26 159 | ||||
| 2013-12-05 | 2013-12-03 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 19,2500 | −22 500 | −433 | 270 967 | ||||
| 2013-12-05 | 2013-12-03 | 4 | Davidar David D | GMED | Class A Common Stock | D | 19,2500 | −52 500 | −1 011 | 897 275 | ||||
| 2013-11-27 | 2013-11-27 | 4 | Demski David M | GMED | Class A Common Stock | D | 19,2500 | −30 447 | −586 | 531 365 | ||||
| 2013-11-27 | 2013-11-26 | 4 | Demski David M | GMED | Class A Common Stock | D | 19,2500 | −6 876 | −132 | 561 812 | ||||
| 2013-11-26 | 2013-11-25 | 4 | WHEELER KURT | GMED | Class A Common Stock | D | −7 000 | 44 319 | ||||||
| 2013-11-04 | 2013-10-31 | 4 | Davidar David D By Berachah Foundation | GMED | Class A Common Stock | I | 18,2000 | −4 545 | −83 | 0 | ||||
| 2013-11-04 | 2013-10-31 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 18,2000 | −20 453 | −372 | 293 467 | ||||
| 2013-11-04 | 2013-10-31 | 4 | Davidar David D | GMED | Class A Common Stock | D | 18,2000 | −47 724 | −869 | 949 775 | ||||
| 2013-11-04 | 2013-11-01 | 4 | Demski David M | GMED | Class A Common Stock | D | 19,2500 | −1 498 | −29 | 568 688 | ||||
| 2013-11-04 | 2013-10-31 | 4 | Demski David M | GMED | Class A Common Stock | D | 19,2600 | −11 179 | −215 | 570 186 | ||||
| 2013-11-04 | 2013-10-31 | 4 | Demski David M | GMED | Class A Common Stock | D | 18,5000 | −100 000 | −1 850 | 581 365 | ||||
| 2013-09-05 | 2013-01-30 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 12,59 | 7 500 | 7 500 | |||||
| 2013-09-05 | 2013-01-30 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 12,59 | 7 500 | 7 500 | |||||
| 2013-09-05 | 2013-09-03 | 4 | LIPTAK ROBERT | GMED | Class A Common Stock | D | 51 159 | 51 159 | ||||||
| 2013-09-05 | 2013-09-03 | 4 | LIPTAK ROBERT By L.P. | GMED | Class A Common Stock | I | −7 244 201 | 0 | ||||||
| 2013-09-05 | 2013-01-30 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 12,59 | 7 500 | 7 500 | |||||
| 2013-09-05 | 2013-09-03 | 4 | WHEELER KURT | GMED | Class A Common Stock | D | 51 319 | 51 319 | ||||||
| 2013-09-05 | 2013-09-03 | 4 | WHEELER KURT By L.P. | GMED | Class A Common Stock | I | −7 244 201 | 0 | ||||||
| 2013-09-05 | 2013-01-30 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 12,59 | 7 500 | 7 500 | |||||
| 2013-09-04 | 2013-09-03 | 4 | Clarus Lifesciences I, L.P. By Fund | GMED | Class A Common Stock | I | −7 244 201 | 0 | ||||||
| 2013-08-26 | 2013-08-23 | 4 | Davidar David D By Berachah Foundation | GMED | Class A Common Stock | I | 18,2000 | −173 | −3 | 4 545 | ||||
| 2013-08-26 | 2013-08-23 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 18,2000 | −779 | −14 | 313 920 | ||||
| 2013-08-26 | 2013-08-23 | 4 | Davidar David D | GMED | Class A Common Stock | D | 18,2000 | −1 818 | −33 | 997 499 | ||||
| 2013-08-26 | 2013-08-22 | 4 | Davidar David D By Berachah Foundation | GMED | Class A Common Stock | I | 18,2000 | −282 | −5 | 4 718 | ||||
| 2013-08-26 | 2013-08-22 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 18,2000 | −1 268 | −23 | 314 699 | ||||
| 2013-08-26 | 2013-08-22 | 4 | Davidar David D | GMED | Class A Common Stock | D | 18,2000 | −2 958 | −54 | 999 317 | ||||
| 2013-08-26 | 2013-08-22 | 4 | Demski David M By wife | GMED | Class A Common Stock | I | 17,9500 | −4 154 | −75 | 0 | ||||
| 2013-08-26 | 2013-08-22 | 4 | Demski David M | GMED | Class A Common Stock | D | 17,9500 | −40 000 | −718 | 681 365 | ||||
| 2013-08-26 | 2013-06-26 | 4 | Demski David M | GMED | Class A Common Stock | D | −40 000 | 721 635 | ||||||
| 2013-07-08 | 2013-07-05 | 4 | Davidar David D By Berachah Foundation | GMED | Class A Common Stock | I | 17,1500 | −10 000 | −172 | 5 000 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Davidar David D By Berachah Foundation | GMED | Class A Common Stock | I | 16,5600 | −20 000 | −331 | 15 000 | ||||
| 2013-06-27 | 2013-06-26 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 17,1691 | −22 500 | −386 | 315 967 | ||||
| 2013-06-27 | 2013-06-26 | 4 | Davidar David D | GMED | Class A Common Stock | D | 17,1691 | −52 500 | −901 | 1 002 275 | ||||
| 2013-06-27 | 2013-06-25 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 16,2500 | −22 500 | −366 | 338 467 | ||||
| 2013-06-27 | 2013-06-25 | 4 | Davidar David D | GMED | Class A Common Stock | D | 16,2500 | −52 500 | −853 | 1 054 775 | ||||
| 2013-06-11 | 2013-01-30 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 12,59 | 3 000 | 3 000 | |||||
| 2013-06-11 | 2012-08-29 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | 1 500 | 1 500 | |||||
| 2013-06-11 | 2012-08-08 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | 3 076 | 3 076 | |||||
| 2013-06-11 | 2012-08-08 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | 3 076 | 3 076 | |||||
| 2013-06-11 | 2012-08-08 | 4 | Payne Steven | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,87 | 3 076 | 3 076 | |||||
| 2013-06-11 | 2012-08-08 | 4 | Payne Steven | GMED | Class A Common Stock | D | 11,1600 | −2 305 | −26 | 20 771 | ||||
| 2013-06-11 | 3 | Payne Steven | GMED | Class A Common Stock | D | 23 076 | ||||||||
| 2013-05-16 | 2013-05-08 | 4 | Davidar David D By Berachah Foundation | GMED | Class A Common Stock | I | 35 000 | 35 000 | ||||||
| 2013-05-16 | 2013-05-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | −35 000 | 1 107 275 | ||||||
| 2013-05-07 | 2013-05-03 | 4 | Demski David M | GMED | Class A Common Stock | D | 16,2500 | −40 000 | −650 | 761 365 | ||||
| 2013-04-24 | 2013-04-22 | 4 | Davidar David D By Davidar Family Irrevocable Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 360 967 | 360 967 | ||||||
| 2013-04-24 | 2013-04-22 | 4 | Davidar David D | GMED | Class A Common Stock | D | 104 927 | 1 142 275 | ||||||
| 2013-04-24 | 2013-04-22 | 4 | Davidar David D By Davidar 2009 Grantor Retained Annuity Trust U/A 8/6/09 | GMED | Class A Common Stock | I | −465 894 | 0 | ||||||
| 2013-04-24 | 2013-04-22 | 4 | Paul David C By Paul Family Irrevocable Trust U/A 4/6/10 | GMED | Class B Common Stock | I | 0,00 | 1 562 573 | 1 562 573 | |||||
| 2013-04-24 | 2013-04-22 | 4 | Paul David C | GMED | Class B Common Stock | D | 0,00 | 821 063 | 24 944 283 | |||||
| 2013-04-24 | 2013-04-22 | 4 | Paul David C By David C. Paul 2010 Grantor Retained Annuity Trust U/A 4/6/10 | GMED | Class B Common Stock | I | 0,00 | −2 383 636 | 0 | |||||
| 2013-03-13 | 2013-03-11 | 4 | Demski David M | GMED | Class A Common Stock | D | 15,0000 | −14 225 | −213 | 801 365 | ||||
| 2013-02-15 | 2013-02-13 | 4 | Demski David M | GMED | Class A Common Stock | D | 15,0000 | −25 775 | −387 | 815 590 | ||||
| 2013-01-31 | 2013-01-30 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 12,8700 | −31 103 | −400 | 121 217 | ||||
| 2013-01-28 | 2012-12-21 | 5 | Paul David C By Sonali Paul Trust | GMED | Class B Common Stock | I | 435 350 | 435 350 | ||||||
| 2013-01-28 | 2012-12-21 | 5 | Paul David C By David C. Paul Trust | GMED | Class B Common Stock | I | 435 350 | 435 350 | ||||||
| 2013-01-28 | 2012-12-21 | 5 | Paul David C | GMED | Class B Common Stock | D | −870 700 | 24 123 220 | ||||||
| 2013-01-28 | 2012-12-27 | 5 | Demski David M | GMED | Class A Common Stock | D | −50 000 | 841 365 | ||||||
| 2013-01-28 | 2013-01-24 | 4 | BARON RICHARD A | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | 25 000 | 25 000 | |||||
| 2013-01-28 | 2013-01-24 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | 25 000 | 25 000 | |||||
| 2013-01-28 | 2013-01-24 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | 48 000 | 48 000 | |||||
| 2013-01-28 | 2013-01-24 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | 25 000 | 25 000 | |||||
| 2013-01-28 | 2013-01-24 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 13,04 | 40 000 | 40 000 | |||||
| 2012-08-31 | 2012-08-29 | 4 | LIPTAK ROBERT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | 15 300 | 15 300 | |||||
| 2012-08-31 | 2012-08-29 | 4 | WHEELER KURT | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | 15 300 | 15 300 | |||||
| 2012-08-31 | 2012-08-29 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | 10 000 | 10 000 | |||||
| 2012-08-31 | 2012-08-29 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | 15 000 | 15 000 | |||||
| 2012-08-31 | 2012-08-29 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | 15 000 | 15 000 | |||||
| 2012-08-31 | 2012-08-29 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 15,34 | 15 000 | 15 000 | |||||
| 2012-08-10 | 2012-08-08 | 4 | RHOADS ANN D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | 15 384 | 15 384 | |||||
| 2012-08-10 | 2012-08-08 | 4 | LIPTAK ROBERT By. L.P. | GMED | Series E Preferred Stock | I | −7 444 168 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | LIPTAK ROBERT By L.P. | GMED | Class A Common Stock | I | 11,1600 | −804 232 | −8 975 | 7 244 201 | ||||
| 2012-08-10 | 2012-08-08 | 4 | LIPTAK ROBERT By L.P. | GMED | Class A Common Stock | I | 7 444 168 | 8 048 433 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | WHEELER KURT By L.P. | GMED | Series E Preferred Stock | I | −7 444 168 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | WHEELER KURT By L.P. | GMED | Class A Common Stock | I | 11,1600 | −804 232 | −8 975 | 7 244 201 | ||||
| 2012-08-10 | 2012-08-08 | 4 | WHEELER KURT By L.P. | GMED | Class A Common Stock | I | 7 444 168 | 8 048 433 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | BARON RICHARD A | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,34 | 92 307 | 92 307 | |||||
| 2012-08-10 | 2012-08-08 | 4 | GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 OFFSHORE HOLDINGS, L.P. See footnotes | GMED | Series E Preferred Stock | I | −7 089 681 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 OFFSHORE HOLDINGS, L.P. See footnotes | GMED | Class B Common Stock | I | −7 089 681 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | GOLDMAN SACHS PRIVATE EQUITY PARTNERS 2004 OFFSHORE HOLDINGS, L.P. See footnotes | GMED | Class A Common Stock | I | 7 089 681 | 7 643 526 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Lemaitre Dan | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,28 | 15 384 | 15 384 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Clarus Lifesciences I, L.P. By Fund | GMED | Series E Preferred Stock | I | −7 444 168 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Clarus Lifesciences I, L.P. By Fund | GMED | Class A Common Stock | I | 11,1600 | −804 232 | −8 975 | 7 244 201 | ||||
| 2012-08-10 | 2012-08-08 | 4 | Clarus Lifesciences I, L.P. By Fund | GMED | Class A Common Stock | I | 7 444 168 | 8 048 433 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock | D | 10,66 | 12 307 | 12 307 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,28 | 15 384 | 15 384 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | 9 230 | 9 230 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Murphy A Brett | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,87 | 9 230 | 9 230 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Murphy A Brett | GMED | Class B Common Stock | D | −92 307 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 11,1600 | −16 910 | −189 | 152 320 | ||||
| 2012-08-10 | 2012-08-08 | 4 | Murphy A Brett | GMED | Class A Common Stock | D | 92 307 | 169 230 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,87 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D By Davidar 2009 Grantor Retained Annuity Trust U/A 8/6/09 | GMED | Class B Common Stock | I | −465 894 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D | GMED | Class B Common Stock | D | −1 141 157 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D By the Berachah Foundation | GMED | Class A Common Stock | I | 11,1600 | −63 076 | −704 | 0 | ||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D By Davidar 2009 Grantor Retained Annuity Trust U/A 8/6/09 | GMED | Class A Common Stock | I | 465 894 | 465 894 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 11,1600 | −103 809 | −1 159 | 1 037 348 | ||||
| 2012-08-10 | 2012-08-08 | 4 | Davidar David D | GMED | Class A Common Stock | D | 1 141 157 | 1 141 157 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock | D | 10,66 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Paul David C | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,87 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Paul David C | GMED | Class B Common Stock | D | −3 039 385 | 24 993 920 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Paul David C | GMED | Class A Common Stock | D | 11,1600 | −3 039 385 | −33 920 | 0 | ||||
| 2012-08-10 | 2012-08-08 | 4 | Paul David C | GMED | Class A Common Stock | D | 3 039 385 | 3 039 385 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 4,88 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 10,66 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Demski David M | GMED | Stock Option (Right to Buy Class A Common Stock) | D | 11,87 | 18 461 | 18 461 | |||||
| 2012-08-10 | 2012-08-08 | 4 | Demski David M | GMED | Class B Common Stock | D | −990 322 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | Demski David M | GMED | Class A Common Stock | D | 11,1600 | −98 957 | −1 104 | 891 365 | ||||
| 2012-08-10 | 2012-08-08 | 4 | Demski David M | GMED | Class A Common Stock | D | 990 322 | 990 322 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | GOLDMAN SACHS GROUP INC See footnotes | GMED | Series E Preferred Stock | I | −7 089 681 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | GOLDMAN SACHS GROUP INC See footnotes | GMED | Class B Common Stock | I | −7 089 681 | 0 | ||||||
| 2012-08-10 | 2012-08-08 | 4 | GOLDMAN SACHS GROUP INC See footnotes | GMED | Class A Common Stock | I | 7 089 681 | 7 643 526 | ||||||
| 2012-08-02 | 3 | LIPTAK ROBERT By L.P. | GMED | Class A Common Stock | I | 604 265 | ||||||||
| 2012-08-02 | 3 | WHEELER KURT By L.P. | GMED | Class A Common Stock | I | 604 265 | ||||||||
| 2012-08-02 | 3 | MULTI-STRATEGY HOLDINGS OFFSHORE ADVISORS, INC. See footnotes | GMED | Class A Common Stock | I | 553 845 | ||||||||
| 2012-08-02 | 3 | Clarus Ventures I, LLC By Fund | GMED | Class A Common Stock | I | 604 265 | ||||||||
| 2012-08-02 | 3 | Murphy A Brett | GMED | Class A Common Stock | D | 76 923 | ||||||||
| 2012-08-02 | 3 | Davidar David D By the Berachah Foundation | GMED | Class A Common Stock | I | 63 076 | ||||||||
| 2012-08-02 | 3 | GOLDMAN SACHS PEP 2004 ADVISORS, L.L.C. See footnotes | GMED | Class A Common Stock | I | 553 845 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
